Tirzepatideyog ib qho tshiab dual agonist ntawm GIP thiab GLP-1 receptors, tau pom zoo rau kev tswj glycemic rau cov neeg laus uas muaj ntshav qab zib hom 2 nrog rau kev tswj qhov hnyav mus ntev rau cov tib neeg uas muaj lub cev qhov hnyav (BMI) ≥30 kg / m², lossis ≥27 kg / m² nrog tsawg kawg ib qho hnyav txog kev sib txuam.
Rau cov ntshav qab zib mellitus, nws txo qis kev yoo mov thiab postprandial qabzib los ntawm kev ncua lub plab zom mov, txhim kho cov piam thaj-dependent insulin secretion, thiab txo qis glucagon tso tawm, nrog kev pheej hmoo ntawm hypoglycemia piv rau cov tshuaj insulin secretagogues. Hauv kev tswj hwm kev rog, nws ob lub hauv paus thiab qhov nruab nrab ua rau txo qis qab los noj mov thiab nce kev siv zog. Kev sim tshuaj ntsuam xyuas tau pom tias 52-72 lub lis piam ntawm kev kho mob tuaj yeem ua tiav qhov nruab nrab lub cev qhov hnyav ntawm 15% -20%, nrog rau kev txhim kho hauv lub duav ncig, ntshav siab, thiab triglycerides.
Cov xwm txheej tsis zoo tshaj plaws yog mob me mus rau nruab nrab cov tsos mob plab, feem ntau tshwm sim hauv thawj ob peb lub lis piam thiab txo qis los ntawm kev nce qib zuj zus. Kev pib kho mob tau pom zoo nyob rau hauv kev ntsuam xyuas ntawm tus kws kho mob endocrinologist lossis tus kws kho qhov hnyav, nrog kev saib xyuas tsis tu ncua ntawm cov piam thaj, lub cev qhov hnyav, thiab lub raum ua haujlwm. Zuag qhia tag nrho, tirzepatide muaj pov thawj-raws li, muaj kev nyab xeeb, thiab kev xaiv kho kom ruaj khov rau cov neeg mob uas xav tau kev tswj glycemic thiab hnyav.
Post lub sij hawm: Aug-27-2025